Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months

Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months

Abstract The coronavirus disease-2019 (COVID-19) pandemic has had a significant impact on patients with underlying malignancy. In this article, we summarize emerging data related to patients with cancer and COVID-19. Among patients with COVID-19, a higher proportion have an underlying diagnosis of c...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Begoña de las Heras, Kamal S. Saini, Frances Boyle, Felipe Ades, Evandro de Azambuja, Ivana Bozovic-Spasojevic, Marco Romano, Marta Capelan, Rajeev Prasad, Pugazhenthi Pattu, Christophe Massard, Chia Portera, Monika Lamba Saini, Brajendra Prasad Singh, Ramachandran Venkitaraman, Richard McNally, Manuela Leone, Enrique Grande, Sudeep Gupta
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Adis, Springer Healthcare 2020-08-01
Saila:Oncology and Therapy
Gaiak:
Cancer
Coronavirus
COVID-19
Immuno-oncology
Malignancy
Mortality
Sarrera elektronikoa:https://doi.org/10.1007/s40487-020-00124-2

Internet

https://doi.org/10.1007/s40487-020-00124-2

Antzeko izenburuak